Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.
Iacovelli R, Farcomeni A, Sternberg CN, Cartenì G, Milella M, Santoni M, Cerbone L, Di Lorenzo G, Verzoni E, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Maria Ruggeri E, Berruti A, Procopio G. Iacovelli R, et al. Among authors: cinieri s. J Urol. 2015 Jun;193(6):1905-10. doi: 10.1016/j.juro.2014.11.092. Epub 2014 Nov 26. J Urol. 2015. PMID: 25433306
Darbepoetin alpha coming of age.
Pedrazzoli P, Cinieri S, Lorusso V, Gamucci T, Secondino S, Silvestris N. Pedrazzoli P, et al. Among authors: cinieri s. Anticancer Res. 2007 Nov-Dec;27(6C):4419-24. Anticancer Res. 2007. PMID: 18214054 Free article. Review.
First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Gebbia V, Lorusso V, Galetta D, Caruso M M, Palomba G, Riccardi F, Borsellino N, Carrozza F, Leo S, Ferraù F, Cinieri S, Mancuso G, Mancarella S, Colucci G. Gebbia V, et al. Among authors: cinieri s. Lung Cancer. 2010 Aug;69(2):218-24. doi: 10.1016/j.lungcan.2009.10.008. Epub 2009 Nov 11. Lung Cancer. 2010. PMID: 19910076 Clinical Trial.
Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies.
Lorusso V, Cinieri S, Giampaglia M, Ciccarese M, Tinelli A, Chiuri V, Manca C, Silvestris N, Gasparini G, Colucci G. Lorusso V, et al. Among authors: cinieri s. Breast. 2010 Jun;19(3):214-8. doi: 10.1016/j.breast.2010.01.015. Epub 2010 Feb 18. Breast. 2010. PMID: 20167491 Free article. Clinical Trial.
Which role for EGFR therapy in breast cancer?
Lorusso V, Forcignano R, Cinieri S, Tinelli A, Porcelli L, Quatrale AE, Chiuri VE. Lorusso V, et al. Among authors: cinieri s. Front Biosci (Schol Ed). 2012 Jan 1;4(1):31-42. doi: 10.2741/s249. Front Biosci (Schol Ed). 2012. PMID: 22202041 Review.
Second-line erlotinib for non-small-cell lung cancer.
Lorusso V, Cinieri S. Lorusso V, et al. Among authors: cinieri s. Lancet Oncol. 2012 Apr;13(4):e141-2; author reply e142. doi: 10.1016/S1470-2045(12)70113-4. Epub 2012 Mar 30. Lancet Oncol. 2012. PMID: 22469123 No abstract available.
276 results